+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Fluoroquinolone restriction to control fluoroquinolone-resistant Clostridium difficile



Fluoroquinolone restriction to control fluoroquinolone-resistant Clostridium difficile



Lancet. Infectious Diseases 17(4): 353-354




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059745953

Download citation: RISBibTeXText

PMID: 28130062

DOI: 10.1016/S1473-3099(17)30052-X


Related references

Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027. Antimicrobial Agents and ChemoTherapy 60(1): 418-423, 2016

Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital. Infection Control and Hospital Epidemiology 30(3): 264-272, 2009

Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile. Journal of Hospital Infection 73(2): 185-187, 2009

gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027. Emerging Infectious Diseases 13(3): 504-505, 2007

Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile. Infection Control and Hospital Epidemiology 28(8): 932-940, 2007

National antimicrobial stewardship and fluoroquinolone-resistant iClostridium difficile in China. Infection and Drug Resistance 10: 329-331, 2017

Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis. Journal of Hospital Infection 91(1): 74-80, 2016

Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection. Antimicrobial Agents and ChemoTherapy 61(6), 2017

Molecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in vitro. Antimicrobial Agents and ChemoTherapy 53(6): 2463-2468, 2009

Multiplex PCR targeting slpA: a rapid screening method to predict common Clostridium difficile ribotypes among fluoroquinolone resistant clinical strains. Pathology 45(6): 595-599, 2014

Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe. Journal of Medical Microbiology 57(Pt 6): 784-789, 2008

Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis. Microbial Drug Resistance (): -, 2016

Fluoroquinolone use and Clostridium difficile-associated diarrhea. Emerging Infectious Diseases 9(6): 730-733, 2003

Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study. Journal of Antimicrobial ChemoTherapy 67(4): 1010-1015, 2012

Fluoroquinolone resistance and Clostridium difficile, Germany. Emerging Infectious Diseases 16(4): 675-677, 2010